rs652572

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.3949+48T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.643 in 1,504,160 control chromosomes in the GnomAD database, including 314,793 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 27238 hom., cov: 31)
Exomes 𝑓: 0.65 ( 287555 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0210

Publications

11 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 13-110167110-A-G is Benign according to our data. Variant chr13-110167110-A-G is described in ClinVar as Benign. ClinVar VariationId is 1269926.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.3949+48T>C intron_variant Intron 44 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.3949+48T>C intron_variant Intron 44 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.588
AC:
89047
AN:
151432
Hom.:
27237
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.400
Gnomad AMI
AF:
0.454
Gnomad AMR
AF:
0.660
Gnomad ASJ
AF:
0.595
Gnomad EAS
AF:
0.654
Gnomad SAS
AF:
0.681
Gnomad FIN
AF:
0.723
Gnomad MID
AF:
0.606
Gnomad NFE
AF:
0.655
Gnomad OTH
AF:
0.586
GnomAD2 exomes
AF:
0.651
AC:
163568
AN:
251176
AF XY:
0.653
show subpopulations
Gnomad AFR exome
AF:
0.393
Gnomad AMR exome
AF:
0.715
Gnomad ASJ exome
AF:
0.599
Gnomad EAS exome
AF:
0.652
Gnomad FIN exome
AF:
0.734
Gnomad NFE exome
AF:
0.657
Gnomad OTH exome
AF:
0.633
GnomAD4 exome
AF:
0.649
AC:
878332
AN:
1352608
Hom.:
287555
Cov.:
21
AF XY:
0.650
AC XY:
441522
AN XY:
679188
show subpopulations
African (AFR)
AF:
0.385
AC:
12118
AN:
31436
American (AMR)
AF:
0.710
AC:
31624
AN:
44566
Ashkenazi Jewish (ASJ)
AF:
0.600
AC:
15287
AN:
25468
East Asian (EAS)
AF:
0.649
AC:
25426
AN:
39174
South Asian (SAS)
AF:
0.659
AC:
55411
AN:
84020
European-Finnish (FIN)
AF:
0.730
AC:
38889
AN:
53286
Middle Eastern (MID)
AF:
0.576
AC:
3066
AN:
5322
European-Non Finnish (NFE)
AF:
0.652
AC:
660042
AN:
1012550
Other (OTH)
AF:
0.642
AC:
36469
AN:
56786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
16041
32083
48124
64166
80207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16574
33148
49722
66296
82870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.588
AC:
89085
AN:
151552
Hom.:
27238
Cov.:
31
AF XY:
0.595
AC XY:
44049
AN XY:
74078
show subpopulations
African (AFR)
AF:
0.400
AC:
16538
AN:
41338
American (AMR)
AF:
0.661
AC:
10070
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.595
AC:
2065
AN:
3468
East Asian (EAS)
AF:
0.654
AC:
3340
AN:
5110
South Asian (SAS)
AF:
0.679
AC:
3263
AN:
4804
European-Finnish (FIN)
AF:
0.723
AC:
7590
AN:
10496
Middle Eastern (MID)
AF:
0.603
AC:
175
AN:
290
European-Non Finnish (NFE)
AF:
0.655
AC:
44387
AN:
67792
Other (OTH)
AF:
0.590
AC:
1247
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1771
3543
5314
7086
8857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
756
1512
2268
3024
3780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.591
Hom.:
8460
Bravo
AF:
0.577
Asia WGS
AF:
0.682
AC:
2374
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.9
DANN
Benign
0.28
PhyloP100
-0.021
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs652572; hg19: chr13-110819457; API